Rajasthan health rights NGO demands urgent probe into child deaths linked to govt-supplied cough syrup

By A Representative 

The Jan Swasthya Abhiyan (JSA) Rajasthan today submitted a memorandum to the state's Health Minister, Shri Gajendra Singh Khimsar, expressing grave concern over the recent tragic deaths of two children and the critical illness of others, which have been reportedly linked to a cough syrup supplied under Rajasthan's free medicines scheme. The JSA emphasized that this incident not only raises alarming questions about the quality control of government-supplied medications but also threatens to erode the hard-won public trust in the state's crucial free medicines program.

The memorandum called for the immediate constitution of an independent, impartial investigation committee. This body, which JSA insists must include senior clinicians, pharmacologists, public health experts, and civil society members, must conduct a transparent inquiry to pinpoint lapses across all levels—manufacturing, testing, or distribution—and ensure accountability is swiftly fixed. JSA firmly stated that the investigation's findings must be made public to maintain transparency.

Beyond the immediate probe, JSA Rajasthan recommended a suite of systemic reforms to prevent any future recurrence of such tragedies. 

These measures include a push to upgrade quality testing technology to advanced analytical tools capable of detecting minor defects, and a demand to make quality test reports of every batch supplied by the Rajasthan Medical Services Corporation Limited (RMSCL) publicly available. JSA also proposed instituting post-supply random batch testing of distributed medicines as an added safety net, and establishing a 24x7 district-level reporting and rapid response system for adverse drug reactions (ADRs) with nodal officers for immediate action. 

Furthermore, the organization called for mandatory root cause analysis (RCA) for every quality failure to identify and correct systemic gaps, along with the establishment of a robust pharmacovigilance system across all public health facilities. Staff sensitization training for frontline health workers, pharmacists, nurses, and doctors to promptly recognize and report adverse reactions was also highlighted as essential. 

Finally, JSA demanded regular public disclosure and audits of medicine quality checks and a system for periodic third-party audits of RMSCL processes by independent institutions to restore and ensure community confidence. 

The JSA underscored that the free medicines scheme is a lifeline for thousands of families and urged the government to act with utmost urgency and transparency to guarantee such tragedies are never repeated.